Jan 9, 2026 Cellectar Biosciences to Highlight Strategic Initiatives for 2026 at Upcoming Biotech Showcase during 44th Annual JP Morgan Healthcare Conference Learn More
Dec 16, 2025 Cellectar Biosciences Announces Strategic Supply Agreement with Ionetix for Actinium-225 and Astatine-211 to Advance Targeted Alpha Therapies Learn More
Nov 13, 2025 Cellectar Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update Learn More
Nov 6, 2025 Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Thursday, November 13, 2025 Learn More